DXOCRO

Oxford, United States Founded: 2017 • Age: 9 yrs
Provides in vitro diagnostic services for oncology research and development.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 8 Brand Intelligence

About DXOCRO

DXOCRO is a company based in Oxford (United States) founded in 2017. It operates as a B2B. DXOCRO offers products and services including In Vitro Diagnostics Services. DXOCRO operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Ontogen and RecurX Bio, among others.

  • Headquarter Oxford, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Diagnostic Oncology Cro, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DXOCRO

DXOCRO offers a comprehensive portfolio of products and services, including In Vitro Diagnostics Services.

Product name locked
Category locked
Primary

Services for in vitro testing in oncology research and development.

Funding Insights of DXOCRO

Premium access

Detailed funding history for DXOCRO

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DXOCRO

Investments
Premium access

Investment portfolio details for DXOCRO

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - DXOCRO

Premium access

Detailed financials for DXOCRO

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Dxocro Comparisons

DXOCRO Primary company
Description
Provides in vitro diagnostic services for oncology research ...
Location
Oxford, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for DXOCRO

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of DXOCRO

DXOCRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Ontogen and RecurX Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
Locked Locked Locked
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
Locked Locked Locked
Vaccines for infectious diseases and cancer immunotherapy are developed.
Locked Locked Locked
AI-based knowledge management platform for enterprises
Locked Locked Locked
Delivers comprehensive preclinical services for oncology drug development.
Locked Locked Locked
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
Premium access

Detailed competitors of DXOCRO

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Dxocro

Premium access

Complete news archive for DXOCRO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DXOCRO

DXOCRO was founded in 2017.

DXOCRO is headquartered in Oxford, United States.

Diagnostic Oncology CRO, LLC is a contract research organization based in Oxford, Connecticut, United States. It specializes in in vitro diagnostics, offering solutions for clinical laboratories and healthcare sectors. The company supports diagnostic development and research activities, focusing on oncology applications to assist pharmaceutical and medical clients.

DXOCRO's top competitors include Ontogen, AlphaVax and Redbud Medicine.

DXOCRO offers In Vitro Diagnostics Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available